Publications by: G. Paul Amminger
Up a level |
Amminger, G. Paul, Lin, Ashleigh, Kerr, Melissa, Weller, Amber, Spark, Jessica, Pugh, Charlotte, O'Callaghan, Sally, Berger, Maximus, Clark, Scott R., Scott, James G., Baker, Andrea, McGregor, Iain, Cotter, David, Sarnyai, Zoltan, Thompson, Andrew, Yung, Alison R., O'Donoghue, Brian, Killackey, Eoin, Mihalopoulos, Cathy, Yuen, Hok Pan, Nelson, Barnaby, and Mcgorry, Patrick D. (2021) Cannabidiol for at risk for psychosis youth: a randomized controlled trial. Early Intervention in Psychiatry, 16 (4). pp. 419-432.
Berger, Maximus, Lavoie, Suzie, McGorry, Patrick D., Nelson, Barnaby, Markulev, Connie, Yuen, Hok-Pan, Schaefer, Miriam, Sarnyai, Zoltán, and Amminger, G. Paul (2020) Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study. Schizophrenia Research, 226. pp. 38-43.
Berger, Maximus, Amminger, G.Paul, McDermott, Robyn, Guest, Paul C., and Sarnyai, Zoltán (2020) Testing the Effects of Dietary Seafood Consumption on Depressive Symptoms. In: Guest, Paul C., (ed.) Clinical and Preclinical Models for Maximizing Healthspan: methods and protocols. Part of the Methods in Molecular Biology book series (MIMB, volume 2138), 2138 . Humana Press, New York, NY, U.S.A, pp. 233-242.
Berger, Maximus, Juster, Robert Paul, Westphal, Sabine, Amminger, G. Paul, Bogerts, Bernhard, Schiltz, Kolja, Bahn, Sabine, Steiner, Johann, and Sarnyai, Zoltan (2018) Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology, 90. pp. 35-42.